Use of Yttrium 90 (Y-90) and its effects Yttrium-90 or Y90is a commonly used isotope in the medical field specially in departments like nuclear medicine and radiation oncology for radiation therapy. This radioisotope is relied upon Read more
TARE vs TACE for Hepatocellular Carcinoma and NET patients Transarterial Chemoembolisation or TACE has been the initial treatment modality for HCC and has a huge body of evidence from several studies and clinical trials. Therefore, for long TACE has Read more
PRRT Treatment Day Overview This overview provides the patient and the caregiver a peek at what to expect during a typical PRRT treatment with Lu177 (Lutathera) and it covers the following aspects of a typical PRRT tre Read more
Radio-theranostics: How Tiny Radioactive Molecules are Personalising Cancer Care The term 'theranostics' is an integration of the words 'therapeutics' and 'diagnostics'. Theranostic agents are paired agents, one an imaging agent that 'sees' the lesion and the other, a co Read more
Everything you need to know about Alpha PSMA Therapy The question that most patients and caregivers ask – What is Targeted Alpha Therapy or Alpha PSMA Therapy? Targeted Alpha PSMA Therapy is a targeted, selective internal cellular level radi Read more
131 Iodine MIBG Therapy For Pediatric Neuroblastoma The Nuclear Medicine Therapy Centre at Fortis Memorial Research Institute (FMRI) is the Only Centre in India Offering Myeloblative MIBG Therapy for High Risk Neuroblastomas in Children. Read more
What is Transarterial Radioembolization (TARE) TARE is a palliative treatment (it means that it does not provide a cure) that helps slow down the disease growth and also helps alleviate symptoms. It is often used as a treatment option fo Read more
Lu177 PRRT For Neuroendocrine Tumors (Nets) PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a small amount of radioactive material that Read more
Which Patients can benefit with PRRT? PRRT is a short form for Peptide Receptor Radionuclide Therapy. It is also known as molecular therapy or radioisotope therapy. PRRT has been found to be very effective in the treatment on ce Read more
Metastasis directed Lu-177 PSMA Therapy in Prostate Cancer Patients with Oligometastatic Disease Oligometastatic prostate cancer (OMPC) that has five or fewer sites of metastasis is considered a transitional state between localized and widespread metastatic tumors. With improvements in Read more
Advancements in PRRT for treating Neuroendocrine tumours and other cancers. A look at Targeted Alpha Therapy Neuroendocrine tumours (NETs) are heterogeneous with varying behaviour. Treatment decisions are taken basis Histological studies plus imaging data and clinical studies. Surgery is a curative Read more
Is PRRT Safe for you? My last article (Which patients can benefit with PPRT?) summed up the fundamentals of Nuclear Medicine PRRT and which patients may benefit from this therapy. Today, I shall be giving you a l Read more
Castration Resistant Prostate Cancer Treatment – Ac225 PSMA Therapy (Targeted Alpha Therapy) In the past one year, the Nuclear Oncology Experts team at the Department of Nuclear Medicine at Fortis Memorial Research Institute has treated 30 new patients of Castrate Resistant Prostate Read more
Medical Travel to India’s Fortis Memorial Research Institute, India – My Experience I am writing this blog to guide patients who would want to come to India for medical treatment. This is a step-by-step logistics guide and is entirely based on my experience and what steps I Read more
My Experience Getting Lu177 PSMA Therapy In India at Fortis Memorial Research Institute (FMRI) I am a Prostate Cancer patient from USA (name withheld on request). I came to India, specifically to the Department of Nuclear Medicine & Molecular Imaging at Fortis Memorial Research Instit Read more
Lowest Cost of Lu177 PSMA Therapy For prostate cancer patients who have become refractory to conventional therapy, the department of Nuclear Medicine & Molecular Imaging at the Fortis Memorial Research Institute (FMRI) in In Read more
225Ac-PSMA-617 – A New Beginning in the Treatment of Chemotherapy-Naive Prostate Cancer Patients For advanced prostate cancer patients or metastatic castration-resistant prostate cancer (mCRPC) patients, conventional treatment modalities, such as surgery, chemotherapy etc. might not pro Read more
An In-Depth look at Prostate Cancer Cancer is an abnormal cellular growth in a specific body region that is able to spread internally and cover other areas. If left untreated, it causes a number of life-threatening conditions Read more
Is PRRT Right for You? Before we go on to discuss the above topic at hand, let me explain PRRT. In PRRT, a radiopeptide is created by combining a small amount of radioactive material or radionuclide (Yttrium-90 or Read more